McDermott + Bull has successfully placed Tom Mock as the Director of Research and Development at NVMedTech. Tom will oversee the completion of one of the company’s main intravascular products, managing its design finalization, initiating GLP animal studies, and completing all FDA regulatory development testing.
Tom brings a wealth of experience from his tenure at Stryker’s neurovascular division, where he advanced from a senior staff engineer to a managerial role, leading engineering teams. His deep expertise in guidewire technology and advanced stroke care solutions has been instrumental in developing innovative medical devices that enhance patient care.
Located in Carson City, NV, NVMedTech is a leading company in the neurovascular medical device industry, focused on developing innovative solutions that improve patient outcomes in neurovascular care.
This search was completed by McDermott + Bull Partner Ken Dropiewski, Director Shelby Varon, and Research Associate Michael Matranga.